128 related articles for article (PubMed ID: 9826133)
1. Localisation of gelatinase activity in epidermal hoof lamellae by in situ zymography.
Mungall BA; Pollitt CC; Collins R
Histochem Cell Biol; 1998 Nov; 110(5):535-40. PubMed ID: 9826133
[TBL] [Abstract][Full Text] [Related]
2. Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis.
Pollitt CC; Pass MA; Pollitt S
Equine Vet J Suppl; 1998 Sep; (26):119-24. PubMed ID: 9932102
[TBL] [Abstract][Full Text] [Related]
3. Zymographic analysis of equine laminitis.
Mungall BA; Pollitt CC
Histochem Cell Biol; 1999 Dec; 112(6):467-72. PubMed ID: 10651098
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
Clegg PD; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
[TBL] [Abstract][Full Text] [Related]
5. Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays.
Zucker S; Mancuso P; DiMassimo B; Lysik RM; Conner C; Wu CL
Clin Exp Metastasis; 1994 Jan; 12(1):13-23. PubMed ID: 8287615
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours.
Rooprai HK; Van Meter T; Rucklidge GJ; Hudson L; Everall IP; Pilkington GJ
Int J Oncol; 1998 Dec; 13(6):1153-7. PubMed ID: 9824624
[TBL] [Abstract][Full Text] [Related]
7. In situ zymography: topographical considerations.
Mungall BA; Pollitt CC
J Biochem Biophys Methods; 2001 Feb; 47(3):169-76. PubMed ID: 11245888
[TBL] [Abstract][Full Text] [Related]
8. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.
Sier CF; Kubben FJ; Ganesh S; Heerding MM; Griffioen G; Hanemaaijer R; van Krieken JH; Lamers CB; Verspaget HW
Br J Cancer; 1996 Aug; 74(3):413-7. PubMed ID: 8695357
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve.
Kherif S; Dehaupas M; Lafuma C; Fardeau M; Alameddine HS
Neuropathol Appl Neurobiol; 1998 Aug; 24(4):309-19. PubMed ID: 9775397
[TBL] [Abstract][Full Text] [Related]
10. A case of anaphylactoid purpura with multiple blister formation: possible pathophysiological role of gelatinase (MMP-9).
Kobayashi T; Sakuraoka K; Iwamoto M; Kurihara S
Dermatology; 1998; 197(1):62-4. PubMed ID: 9693190
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases.
Quesada AR; Barbacid MM; Mira E; Fernández-Resa P; Márquez G; Aracil M
Clin Exp Metastasis; 1997 Jan; 15(1):26-32. PubMed ID: 9009103
[TBL] [Abstract][Full Text] [Related]
12. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.
Remacle AG; Noël A; Duggan C; McDermott E; O'Higgins N; Foidart JM; Duffy MJ
Br J Cancer; 1998 Mar; 77(6):926-31. PubMed ID: 9528836
[TBL] [Abstract][Full Text] [Related]
13. Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2.
Todor DR; Lewis I; Bruno G; Chyatte D
Stroke; 1998 Aug; 29(8):1580-3. PubMed ID: 9707196
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
15. Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis.
Lafuma C; El Nabout RA; Crechet F; Hovnanian A; Martin M
J Invest Dermatol; 1994 Jun; 102(6):945-50. PubMed ID: 8006459
[TBL] [Abstract][Full Text] [Related]
16. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.
Davies B; Waxman J; Wasan H; Abel P; Williams G; Krausz T; Neal D; Thomas D; Hanby A; Balkwill F
Cancer Res; 1993 Nov; 53(22):5365-9. PubMed ID: 8221672
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints.
Clegg PD; Burke RM; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):335-42. PubMed ID: 9306058
[TBL] [Abstract][Full Text] [Related]
18. Local activity of matrix metalloproteinases in a case of botryoid sarcoma.
Rechberger T; Postawski K; Skorupski P; Kotarski J; Jakowicki JA
Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):169-72. PubMed ID: 8841807
[TBL] [Abstract][Full Text] [Related]
19. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs.
Tatsuguchi A; Fukuda Y; Ishizaki M; Yamanaka N
Digestion; 1999; 60(3):246-54. PubMed ID: 10343138
[TBL] [Abstract][Full Text] [Related]
20. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.
Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N
J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]